Raphael Mechoulam
Oprichter bij CannBioRex Pharmaceuticals Corp.
Profiel
Raphael Mechoulam is the founder of CannBioRex Pharmaceuticals Corp.
which was founded in 2018.
He held the title of Member-Scientific Advisory Board at the company.
Currently, he is a Member at Israel Academy of Sciences & Humanities.
In the past, he held the position of President at International Cannabinoid Research Society.
Actieve functies van Raphael Mechoulam
| Bedrijven | Functie | Begin |
|---|---|---|
CannBioRex Pharmaceuticals Corp.
 CannBioRex Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology CannBioRex Pharmaceuticals Corp. is a research company that specializes in the clinical development of synthetic pharmaceutical grade cannabinoid compounds for the treatment in rheumatoid arthritis and related arthritic diseases. It also plans to develop novel orally available and patentable medications to treat arthritis, multiple sclerosis, diabetes, psoriasis, obesity and fatty liver, and various painful conditions. The company was founded by Marc Feldmann and Raphael Mechoulam on March 8, 2018 and is headquartered in Toronto, Canada. | Oprichter | 08-03-2018 |
Israel Academy of Sciences & Humanities
 Israel Academy of Sciences & Humanities Miscellaneous Commercial ServicesCommercial Services The Israel Academy of Sciences & Humanities is the national academy of science in Israel. The private company is based in Jerusalem, Israel. The academy sees the promotion and developer of the basic scientific research system of a target of national importance. Founded in 1961, its aim is to concentrate on the best of personal science residents, nurturing and promoting scientific activity, advising the government on research and scientific planning of national importance, having contact with parallel bodies outside-to represent Israeli science in institutions and in international conferences and publish reporters to promote science. | Corporate Officer/Principal | - |
Eerdere bekende functies van Raphael Mechoulam
| Bedrijven | Functie | Einde |
|---|---|---|
| International Cannabinoid Research Society | President | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
CannBioRex Pharmaceuticals Corp.
CannBioRex Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology CannBioRex Pharmaceuticals Corp. is a research company that specializes in the clinical development of synthetic pharmaceutical grade cannabinoid compounds for the treatment in rheumatoid arthritis and related arthritic diseases. It also plans to develop novel orally available and patentable medications to treat arthritis, multiple sclerosis, diabetes, psoriasis, obesity and fatty liver, and various painful conditions. The company was founded by Marc Feldmann and Raphael Mechoulam on March 8, 2018 and is headquartered in Toronto, Canada. | Health Technology |
Israel Academy of Sciences & Humanities
Israel Academy of Sciences & Humanities Miscellaneous Commercial ServicesCommercial Services The Israel Academy of Sciences & Humanities is the national academy of science in Israel. The private company is based in Jerusalem, Israel. The academy sees the promotion and developer of the basic scientific research system of a target of national importance. Founded in 1961, its aim is to concentrate on the best of personal science residents, nurturing and promoting scientific activity, advising the government on research and scientific planning of national importance, having contact with parallel bodies outside-to represent Israeli science in institutions and in international conferences and publish reporters to promote science. | Commercial Services |
| International Cannabinoid Research Society |